No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants.

Authors:
He Q; Xia B; Meng W; Fan D; Kuo ZC and 9 more

Journal:
Am J Gastroenterol

Publication Year: 2021

DOI:
10.14309/ajg.0000000000001377

PMCID:
PMC8560155

PMID:
34313608

Journal Information

Full Title: Am J Gastroenterol

Abbreviation: Am J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST Guarantor of the article: Jinqiu Yuan, PhD. Specific author contributions: Qiangsheng He, MM, Bin Xia, PhD, and Wenbo Meng, MD, PhD, contributed equally to this study. M.Y., Y.P., and J.Y.: concept and design. All authors: acquisition, analysis, or interpretation of data. J.Y., M.Y., and W.M.: drafting of the article. All authors: critical revision of the article for important intellectual content. Q.H., J.Y., and B.X.: statistical analysis. M.Y., Y.P., and B.X.: obtained funding. Y.P. and J.Y.: administrative, technical, or material support. Y.P. and J.Y.: supervision. Financial support: This work was supported by the National Natural Science Foundation of China (82003408 and 82003524), the Startup Fund for the 100 Top Talents Program, SYSU (392012), Guangdong Provincial Key Laboratory of Digestive Cancer Research, No. 2021B1212040006), and the National Key Research and Development Program (2018YFA0902801). Potential competing interests: None to report."

Evidence found in paper:

"Financial support: This work was supported by the National Natural Science Foundation of China (82003408 and 82003524), the Startup Fund for the 100 Top Talents Program, SYSU (392012), Guangdong Provincial Key Laboratory of Digestive Cancer Research, No. 2021B1212040006), and the National Key Research and Development Program (2018YFA0902801)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025